KATELYN LYNE: Open Payments
NPI 1588258768 · COLONIAL HEIGHTS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 36 payments from 17 companies in 2025. Trend: 2023 $1,685 · 2024 $819 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $189 |
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| Abbott Laboratories | 1 | $132 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| SCPHARMACEUTICALS INC. | 3 | $81 |
| Novo Nordisk Inc | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| BridgeBio Pharma, Inc. | 2 | $32 |
Products named: LEQVIO, FARAPULSE, MITRACLIP, WAINUA, FUROSCIX, Wegovy, VERQUVO, WATCHMAN FLX.
Industry payments across VA — which companies pay providers there.
